Literature DB >> 32364501

Risk of coronary obstruction and the need to perform BASILICA: the VIVID classification.

Gilbert H L Tang1, Ikki Komatsu, Liron Tzemach, Matheus Simonato, Arik Wolak, Philipp Blanke, Danny Dvir.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32364501     DOI： 10.4244/EIJ-D-20-00067

Source DB:  PubMed          Journal:  EuroIntervention        ISSN： 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  4 in total

Review 1.  Transcatether Aortic Valve Implantation to Treat Degenerated Surgical Bioprosthesis: Focus on the Specific Procedural Challenges.

Authors:  Cristina Aurigemma; Francesco Burzotta; Rocco Vergallo; Piero Farina; Enrico Romagnoli; Stefano Cangemi; Francesco Bianchini; Marialisa Nesta; Piergiorgio Bruno; Domenico D'Amario; Antonio Maria Leone; Carlo Trani
Journal:  Front Cardiovasc Med       Date:  2022-05-31

2.  New adverse coronary events in valve-in-valve TAVR and native TAVR-A 2-year matched cohort.

Authors:  Ofir Koren; Vivek Patel; Robert Naami; Edmund Naami; Takashi Nagasaka; Alon Shechter; Sharon Shalom Natanzon; Siamak Kohan; Zev Allison; Addee Lerner; Daniel Eugene Cheng; Tarun Chakravarty; Mamoo Nakamura; Wen Cheng; Hasan Jilaihawi; Raj R Makkar
Journal:  Front Cardiovasc Med       Date:  2022-09-21

Review 3.  Trans-Catheter Valve-in-Valve Implantation for the Treatment of Aortic Bioprosthetic Valve Failure.

Authors:  Andrea Buono; Diego Maffeo; Giovanni Troise; Francesco Donatelli; Maurizio Tespili; Alfonso Ielasi
Journal:  J Clin Med       Date:  2022-01-11       Impact factor: 4.241

4.  An unintentional complication during an intentional procedure-Sinus of Valsalva laceration during BASILICA.

Authors:  Norman Mangner; Mohamed Abdel-Wahab; Krunoslav Sveric; Utz Kappert; Julia Fischer; Stephan Haussig; Axel Linke
Journal:  Clin Res Cardiol       Date:  2020-09-21       Impact factor: 5.460
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.